Application Nr Approved Date Route Status External Links
ANDA040284 1998-06-19 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Orphenadrine Citrate Extended-Release Tablets Are Indicated As An Adjunct To Rest, Physical Therapy, And Other Measures For The Relief Of Discomfort Associated With Acute Painful Musculoskeletal Conditions.

All Formulated Excipients (1 Total)

Name Structure Kind Function Status
1. Hypromelloses HYPROMELLOSES Unresolved

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Orphenadrine Citrate ORPHENADRINE CITRATE ZINC155269

Comments